These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 21034670)

  • 1. Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
    Kroeger KM; Muhammad AK; Baker GJ; Assi H; Wibowo MK; Xiong W; Yagiz K; Candolfi M; Lowenstein PR; Castro MG
    Discov Med; 2010 Oct; 10(53):293-304. PubMed ID: 21034670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
    Chiocca EA; Nassiri F; Wang J; Peruzzi P; Zadeh G
    Neuro Oncol; 2019 Jan; 21(1):14-25. PubMed ID: 30346600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance.
    Totsch SK; Schlappi C; Kang KD; Ishizuka AS; Lynn GM; Fox B; Beierle EA; Whitley RJ; Markert JM; Gillespie GY; Bernstock JD; Friedman GK
    Oncogene; 2019 Aug; 38(34):6159-6171. PubMed ID: 31289361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting role of glioma stem cells for glioblastoma multiforme.
    Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ
    Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies.
    Bernstock JD; Hoffman SE; Chen JA; Gupta S; Kappel AD; Smith TR; Chiocca EA
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34204248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques.
    Czarnywojtek A; Borowska M; Dyrka K; Van Gool S; Sawicka-Gutaj N; Moskal J; Kościński J; Graczyk P; Hałas T; Lewandowska AM; Czepczyński R; Ruchała M
    Pharmacology; 2023; 108(5):423-431. PubMed ID: 37459849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune and viral therapies for malignant primary brain tumors.
    Gardeck AM; Sheehan J; Low WC
    Expert Opin Biol Ther; 2017 Apr; 17(4):457-474. PubMed ID: 28274139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma.
    Kane JR; Miska J; Young JS; Kanojia D; Kim JW; Lesniak MS
    Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii24-ii36. PubMed ID: 25746089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas.
    Estevez-Ordonez D; Chagoya G; Salehani A; Atchley TJ; Laskay NMB; Parr MS; Elsayed GA; Mahavadi AK; Rahm SP; Friedman GK; Markert JM
    Neurosurg Clin N Am; 2021 Apr; 32(2):265-281. PubMed ID: 33781507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.
    Candolfi M; Kroeger KM; Muhammad AK; Yagiz K; Farrokhi C; Pechnick RN; Lowenstein PR; Castro MG
    Curr Gene Ther; 2009 Oct; 9(5):409-21. PubMed ID: 19860655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oncolytic viruses and viral vectors on immunity in glioblastoma.
    Liu P; Wang Y; Wang Y; Kong Z; Chen W; Li J; Chen W; Tong Y; Ma W; Wang Y
    Gene Ther; 2022 Apr; 29(3-4):115-126. PubMed ID: 33191399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging immunotherapies for glioblastoma.
    Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Immunotherapeutic Approaches for Glioblastoma.
    Vázquez Cervantes GI; González Esquivel DF; Gómez-Manzo S; Pineda B; Pérez de la Cruz V
    J Immunol Res; 2021; 2021():3412906. PubMed ID: 34557553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.
    Duebgen M; Martinez-Quintanilla J; Tamura K; Hingtgen S; Redjal N; Wakimoto H; Shah K
    J Natl Cancer Inst; 2014 Jun; 106(6):dju090. PubMed ID: 24838834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas.
    Rath P; Shi H; Maruniak JA; Litofsky NS; Maria BL; Kirk MD
    Curr Stem Cell Res Ther; 2009 Jan; 4(1):44-9. PubMed ID: 19149629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.
    Kanai R; Rabkin SD
    CNS Oncol; 2013 Mar; 2(2):129-42. PubMed ID: 23687568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment.
    Francipane MG; Douradinha B; Chinnici CM; Russelli G; Conaldi PG; Iannolo G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.
    Wakimoto H; Kesari S; Farrell CJ; Curry WT; Zaupa C; Aghi M; Kuroda T; Stemmer-Rachamimov A; Shah K; Liu TC; Jeyaretna DS; Debasitis J; Pruszak J; Martuza RL; Rabkin SD
    Cancer Res; 2009 Apr; 69(8):3472-81. PubMed ID: 19351838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral Control of Glioblastoma.
    Mihelson N; McGavern DB
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Approaches and Challenges in the Molecular Therapeutic Targeting of Glioblastoma.
    Mooney J; Bernstock JD; Ilyas A; Ibrahim A; Yamashita D; Markert JM; Nakano I
    World Neurosurg; 2019 Sep; 129():90-100. PubMed ID: 31152883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.